Britain to provide anti-viral drug remdesivir to some COVID-19 patients

Britain will provide anti-viral drug remdesivir to certain COVID-19 patients that it is most likely to benefit as part of a collaboration with manufacturer Gilead Sciences, the health ministry said on Tuesday.

>>Reuters
Published : 26 May 2020, 10:50 AM
Updated : 26 May 2020, 10:50 AM

The department of health said that early data from clinical trials around the world, including the UK, showed that the drug could shorten the recovery time of COVID-19 patients by 4 days. It did not say how many patients would be treated under the arrangement.